(Q42980109)
Statements
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients (English)
L Falcato
S Dober
B Helbling
O Keiser
F Negro
D Meili
Swiss Hepatitis C Cohort Study